top of page
Browse by category
Search
AOMs result in 8% relative risk reduction in any CVD events in patients with obesity
The utilisation of anti-obesity medications (AOMs) among people with obesity could potentially alleviate the high prevalence of...
Nearly two-thirds of people stop taking weight loss drugs due to side effects and cost
The majority of patients prescribed weight loss drugs for obesity stop taking them because of side effects and cost, according to the...
Banded-RYGB outcomes show maintenance of weight loss out to ten years
The addition of a silicone ring to a Roux-en-Y gastric bypass (banded- RYGB) results in the maintenance of weight loss ten years...
Looking forward to IFSO 2024
This year’s 27th IFSO World Congress returns to Australia for the first time since the 11th World Congress in Sydney in 2006. We caught...
Latest findings from the IFSO Global Registry
Registries offer opportunities to make meaningful comparisons between countries on the demographics, characteristics, operation types and...
Tirzepatide associated with a potential targeted effect on visceral fat and liver fat
Exploratory analysis from the SURPASS-3 MRI study has shown a significant reduction of both visceral- and liver fat z-scores, and a shift...
No significant differences between LigaSure and Harmonic in LSG outcomes
There are no significant differences between LigaSure (Medtronic) and Harmonic (Ethicon Endo-Surgery) devices in terms of operative time,...
Endoscopic BariTon™ implant intended to mimic sleeve gastrectomy and bypass surgery
In February 2024, BariaTek Medical announced that it had successfully performed the first-in-human implant of the BariTon™, an...
US researchers to assess the impact of physical activity after bariatric surgery
A research team at the Hartford HealthCare Digestive Health Institute (DHI) will launch a new study, funded by a US$2.9-million federal...
GLP-1RAs may lead to increased risk of aspiration pneumonia following endoscopy
People who are scheduled for certain medical procedures should stop taking glucagon-like peptide-1 receptor agonists (GLP-1RAs)...
Browse by tag
bottom of page